Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemodialysis and CAPD--are they comparable?

K D Nolph1

  • 1Department of Internal Medicine, University of Missouri-Columbia, USA.

Przeglad Lekarski
|December 19, 1998
PubMed
Summary

Hemodialysis (HD) and peritoneal dialysis (PD) show similar patient survival rates. However, peritoneal dialysis likely offers better quality of life and cost-effectiveness for many patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reply to Dr. Charles Schleifer about "PD First".

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2007
Same author

Serum insulin-like growth factor I levels do not correlate with residual renal function in dialysis patients.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002
Same author

Cardiovascular comorbidity and mortality in patients starting peritoneal dialysis: an American midwestern center experience.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2001
Same author

Past, present, and future of quantified peritoneal dialysis.

Seminars in dialysis·2001
Same author

Peritoneal dialysis should be the first choice of initial renal replacement therapy for more patients with end-stage renal disease.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2001
Same author

Argument for timely initiation of dialysis.

Journal of the American Society of Nephrology : JASN·2001

Area of Science:

  • Nephrology
  • Renal Replacement Therapy

Background:

  • End-stage renal disease necessitates renal replacement therapy.
  • Hemodialysis (HD) and peritoneal dialysis (PD) are common treatment modalities.

Purpose of the Study:

  • To compare thrice-weekly hemodialysis (HD) with peritoneal dialysis (PD), primarily continuous ambulatory PD (CAPD).
  • To evaluate patient survival, cost, and quality of life between HD and PD.

Main Methods:

  • Comparative analysis of thrice-weekly HD versus PD (mainly CAPD).
  • Assessment of patient survival, economic factors, and quality of life metrics.

Main Results:

  • No statistically significant difference in patient survival between HD and PD was identified.
  • PD demonstrated probable advantages in terms of cost and quality of life for a significant patient cohort.
  • Earlier initiation of dialysis and incremental prescriptions for targeted small-solute clearances favored PD for cost and technical benefits.

Conclusions:

  • Neither HD nor PD offers a proven survival advantage.
  • PD presents a potentially more cost-effective and quality-of-life-enhancing option for many patients undergoing dialysis.
  • The trend towards earlier dialysis initiation and optimized solute clearance supports PD's advantages.

Related Experiment Videos